USE OF ANASTROZOLE AND VITAMIN D ANALOGUE IN THE COMBINED THERAPY OF BREAST CANCER

The invention relates to the use of anastrozole and vitamin D analogues in combined therapy of breast cancer. Vitamin D analogues are selected from a group including calcipotriol, tacalcitol and (1S,3R,5E,7E,22E,24S)-24-cyclopropyl-9,10-secochola- 5,7,10(19),22-tetraen-l,3,24-triol (isomer 5,6-trans...

Full description

Saved in:
Bibliographic Details
Main Authors KUTNER, ANDRZEJ, WIETRZYK, JOANNA, CHODYNSKI, MICHAL, FILIP-PSURSKA, BEATA
Format Patent
LanguageEnglish
French
Published 27.09.2012
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the use of anastrozole and vitamin D analogues in combined therapy of breast cancer. Vitamin D analogues are selected from a group including calcipotriol, tacalcitol and (1S,3R,5E,7E,22E,24S)-24-cyclopropyl-9,10-secochola- 5,7,10(19),22-tetraen-l,3,24-triol (isomer 5,6-trans of calcipotriol). L'invention concerne l'utilisation d'anastrozole et d'analogues de la vitamine D en polythérapie contre le cancer du sein. Les analogues de la vitamine D sont choisis dans un groupe comprenant le calcipotriol, le tacalcitol et le (1S,3R,5E,7E,22E,24S)-24-cyclopropyl-9,10-secochola- 5,7,10(19),22-tetraèn-l,3,24-triol (isomère 5,6-trans de calcipotriol).
Bibliography:Application Number: WO2012PL00012